Bruker (BRKR) to Acquire PhenomeX (CELL) for $1/sh or $108M Cash streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Acquisition initiates Bruker’s entry into functional single-cell biology research solutionsBILLERICA, Mass. & EMERYVILLE, Calif. (BUSINESS WIRE) #BRKR Bruker Corporation (Nasdaq: BRKR) and PhenomeX Inc. (Nasdaq: CELL) today announced that they have signed a definitive agreement for Bruker to acquire PhenomeX for.
Operator: Good morning and welcome to Bruker s Second Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions].
Total revenue increased 2.5% year-over-year to $766.0 million.
Net income increased 55.6% year-over-year to $16.8 million; reflects 80-basis point expansion in Net income margin.
Adjusted.